Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

CYTK holding history

Cytokinetics Inc in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CYTK overviewAll 13F holders of CYTKFull Q2 2026 holdings

Shares (Q2 2026)
3,990
Value
$339.9K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CYTK by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,990$339.9K<0.1%−60−1.5%ReducedHolders
Q1 20264,050$266.9K<0.1%−870−17.7%ReducedHolders
Q4 20254,920$312.6K<0.1%+612+14.2%AddedHolders
Q3 20254,308$236.8K<0.1%+2,584+149.9%AddedHolders
Q2 20251,724$57.0K<0.1%−686−28.5%ReducedHolders
Q1 20252,410$96.9K<0.1%+672+38.7%AddedHolders
Q4 20241,738$81.8K<0.1%−3,552−67.1%ReducedHolders
Q3 20245,290$279.3K<0.1%−1,752−24.9%ReducedHolders
Q2 20247,042$381.5K<0.1%+1,408+25.0%AddedHolders
Q1 20245,634$395.0K<0.1%+2,265+67.2%AddedHolders
Q4 20233,369$281.3K<0.1%−9,601−74.0%ReducedHolders
Q3 202312,970$382.1K<0.1%−4,568−26.0%ReducedHolders
Q2 202317,538$572.1K<0.1%−1,502−7.9%ReducedHolders
Q1 202319,040$670.0K<0.1%−608−3.1%ReducedHolders
Q4 202219,648$900.3K<0.1%−523−2.6%ReducedHolders
Q3 202220,171$977.0K<0.1%−5,120−20.2%ReducedHolders
Q2 202225,291$994.0K<0.1%+6,274+33.0%AddedHolders
Q1 202219,017$700.0K<0.1%−165−0.9%ReducedHolders
Q4 202119,182$874.0K<0.1%−169−0.9%ReducedHolders
Q3 202119,351$692.0K<0.1%+17,664+1,047.1%AddedHolders
Q2 20211,687$33.0K<0.1%+998+144.8%AddedHolders
Q1 2021689$16.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.